Protalix Pipeline

Protalix Pipeline
Home / Pipeline

Pipeline Overview

Our pipeline consists of proprietary, potentially clinically superior versions of recombinant therapeutic proteins that target established pharmaceutical markets. All of our pipeline candidates are proteins expressed via our proprietary ProCellEx® system.

We are advancing clinical programs addressing Fabry disease, cystic fibrosis, and immune and inflammatory diseases. In addition, Protalix is conducting initial research to evaluate additional programs for developing proprietary proteins with improved clinical profiles exploiting the unique nature of plant cell expression.

Pipeline Overview

PHASE I
PHASE II
PHASE III